BackGC Biopharma Overview

GC Biopharma Current Assets

Latest current assets for 006280.KS: $1.4T.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$1358.10B
↓ 6.60% YoYΔ $-96.04B vs prior year quarter

Peer trimmed avg / median

Loading

GC Biopharma Current Assets History

Loading

GC Biopharma vs. peers: Current Assets Comparison

Loading

GC Biopharma Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GC Biopharma (006280.KS) FAQ

The latest current assets for 006280.KS is $1.4T as of June 2026. That compares with $1.5T in the prior-year period — down 6.6% year over year. Investors often review this figure alongside GC Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, 006280.KS's current assets moved from $1.5T to $1.4T — a 6.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GC Biopharma's operating scale or balance-sheet position.

A current assets figure of $1.4T for 006280.KS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 006280.KS's current assets ($1.4T), review year-over-year change from $1.5T, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.